Nucleus Genomics
PrivateLast Round
Series A
Jan 30, 2025
Total Funding Raised
$31.5M
Company Overview
Nucleus Genomics is a biotechnology company that provides direct-to-consumer whole-genome sequencing and analysis for health risks, family planning, and preventative health.
Sector
Healthcare & Life Sciences
Verticals
Precision Medicine, Biotechnology, D2C Brands, Healthcare Analytics
Business Model
B2C
Customer Profile
Hardware Sales, Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nucleus Genomics Comparables
Compare Nucleus Genomics with similar companies based on industry and business-model similarity.
Nucleus Genomics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | Jan 30, 2025 | ||||
| Seed | Jul 14, 2022 | ||||
| Pre Seed | Dec 15, 2021 |
Nucleus Genomics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Rose Street Capital | Series A |
| Neo | Series A |
| Founders Fund | Seed, Series A, Pre Seed |
| Asylum Ventures | Series A |
| Seven Seven Six | Seed, Series A |
| Common Metal | Series A |
| Samsung Next TLV | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 30, 2025
$14M round led by Founders Fund and Seven Seven Six.
- Jul 14, 2022
$14M round led by Seven Seven Six.
Nucleus Genomics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Nucleus Genomics's valuation, stock price, and market status.